Analyst Perspectives in Consideration for Memorial Resource Development Corp. (NASDAQ:MRD), Boston Scientific Corporation (NYSE:BSX)

For the current quarter, analysts are expecting Memorial Resource Development Corp. (NASDAQ:MRD) to report EPS of $N/A. This consensus estimate is provided by Zacks Research. After the period that ended on N/A, Memorial Resource Development Corp. (NASDAQ:MRD) reported an EPS actual of $N/A. The difference between the actual and estimate resulted in a surprise factor of -15.38%. The company is expected to release their next earnings report on or around N/A. Interested parties will be watching to see how company results compare to what the Street was projecting for the fiscal period.

Shares of Memorial Resource Development Corp. (NASDAQ:MRD) have a current ABR or average broker rating of N/A. This consensus recommendation is also provided by Zacks Research. The recommendation falls on a scale between 1 and 5. A broker rating of 1 would translate into a Strong Buy. A rating of 5 would indicate a Strong Sell recommendation. This consensus broker rating may help shed some light on how the sell-side is currently viewing company stock.

Covering analysts often provide target price projections for company shares. The current Zacks consensus target price on shares of Memorial Resource Development Corp. (NASDAQ:MRD) is $N/A. The top analyst target is $N/A, and the lowest target is $N/A on the stock. Because of the different techniques used to gauge a company target price, estimates may be quite different from one analyst to another.

Boston Scientific Corporation (NYSE:BSX) shares have a current ABR (average broker recommendation) of 1.63. This recommendation is offered by Zacks Research. The rating lands on a sliding numerical scale from 1 to 5. A recommendation of 5 would indicate a Strong Sell, and a 1 would signify a Strong Buy. The mean rating may help provide a general sense of analyst sentiment on company shares.

Sell-side analysts taken into consideration by Zacks have also provided price target estimates on shares of Boston Scientific Corporation (NYSE:BSX). The highest current target is $30. The lowest price target out of the polled analysts is presently $24. The consensus target price is currently noted at $27.437. Analysts may employ various techniques to help predict future stock price levels.

On the earnings front, Boston Scientific Corporation (NYSE:BSX) is expected to post quarterly earnings per share of $0.3. This is the current consensus figure provided by Zacks. Investors and analysts will be looking for the company to next post earnings on or around 2017-04-27. Boston Scientific Corporation (NYSE:BSX) most recently reported quarterly EPS of $0.3 for the quarter ending 2016-12-31. The gap between the actual and the projected estimate leading up to earnings created a surprise factor of 3.45%.

Leave a Comment